These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 12881707

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116.
    Choi JH, Min NY, Park J, Kim JH, Park SH, Ko YJ, Kang Y, Moon YJ, Rhee S, Ham SW, Park AJ, Lee KH.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):449-54. PubMed ID: 19914212
    [Abstract] [Full Text] [Related]

  • 43. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA.
    Oncogene; 2001 Nov 22; 20(53):7787-96. PubMed ID: 11753657
    [Abstract] [Full Text] [Related]

  • 44. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C, Li H, Zhou G, Zhang Q, Zhang T, Li J, Zhang J, Hou J, Liew CT, Yin D.
    J Pathol; 2007 Jun 22; 212(2):134-42. PubMed ID: 17471463
    [Abstract] [Full Text] [Related]

  • 45. Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.
    Claus R, Fliegauf M, Stock M, Duque JA, Kolanczyk M, Lübbert M.
    J Leukoc Biol; 2006 Dec 22; 80(6):1462-72. PubMed ID: 17000900
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X, Nelson WG.
    Cancer Res; 2003 Jan 15; 63(2):498-504. PubMed ID: 12543808
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer.
    Ullerås E, Miller SJ, Adam GI, Kanduri C, Wilcock AC, Franklin GC.
    Exp Cell Res; 2001 Nov 01; 270(2):188-98. PubMed ID: 11640883
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Analysis of methylation pattern in multiple myeloma.
    San-Miguel J, García-Sanz R, López-Pérez R.
    Acta Haematol; 2005 Nov 01; 114 Suppl 1():23-6. PubMed ID: 16166769
    [Abstract] [Full Text] [Related]

  • 59. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
    Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE.
    Mol Endocrinol; 2005 Jul 01; 19(7):1740-51. PubMed ID: 15746193
    [Abstract] [Full Text] [Related]

  • 60. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b.
    Suzuki M, Yamada T, Kihara-Negishi F, Sakurai T, Hara E, Tenen DG, Hozumi N, Oikawa T.
    Oncogene; 2006 Apr 20; 25(17):2477-88. PubMed ID: 16331260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.